Eko-Diagnostic Profile
Key Indicators
- Authorised Capital ₹ 5.70 Cr
as on 18-07-2024
- Paid Up Capital ₹ 1.66 Cr
as on 18-07-2024
- Company Age 36 Year, 11 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 81.45 Cr
as on 18-07-2024
- Satisfied Charges ₹ 110.05 Cr
as on 18-07-2024
- Revenue 6.74%
(FY 2023)
- Profit 30.42%
(FY 2023)
- Ebitda -2.55%
(FY 2023)
- Net Worth 8.35%
(FY 2023)
- Total Assets -3.27%
(FY 2023)
About Eko-Diagnostic
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 5.70 Cr and a paid-up capital of Rs 1.66 Cr.
The company currently has active open charges totaling ₹81.45 Cr. The company has closed loans amounting to ₹110.05 Cr, as per Ministry of Corporate Affairs (MCA) records.
Jeetendra Sharma, Nand Rathore, and Surendra Kumar serve as directors at the Company.
- CIN/LLPIN
U85120WB1987PTC043172
- Company No.
043172
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
16 Oct 1987
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Kolkata
Industry
Company Details
- Location
Cal-71., West Bengal, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Eko-Diagnostic?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Jeetendra Sharma  | Director | 24-Sep-2003 | Current |
| Nand Rathore | Director | 20-Dec-1990 | Current |
| Surendra Kumar | Director | 16-Oct-1987 | Current |
Financial Performance and Corporate Structure Insights of Eko-Diagnostic.
Eko-Diagnostic Pvt Ltd, for the financial year ended 2023, experienced modest growth in revenue, with a 6.74% increase. The company also saw a substantial improvement in profitability, with a 30.42% increase in profit. The company's net worth moved up by a moderate rise of 8.35%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Eko-Diagnostic?
In 2023, Eko-Diagnostic had a promoter holding of 83.10% and a public holding of 16.89%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Calcutta Medical Imaging Institute Ltd
Active
35 years 1 month Jeetendra Sharma, Nand Rathore and 1 more are mutual person
Anusuya Sharma Medical Education Foundation
Active 28 years 1 month Nand Rathore and Surendra Kumar are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 28 Feb 2022 | ₹1.30 Cr | Open |
Others Creation Date: 06 Oct 2020 | ₹5.99 M | Open |
Hdfc Bank Limited Creation Date: 25 Oct 2019 | ₹5.00 Cr | Open |
How Many Employees Work at Eko-Diagnostic?
Unlock and access historical data on people associated with Eko-Diagnostic, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
As of Mar 31, 2014, Eko-Diagnostic has raised a total of ₹ 2.81 Cr, with the most recent deal valued at ₹ 2.81 Cr. Access detailed insights into the company’s deals, including security allotments, mergers, acquisitions, and strategic partnerships that have shaped its growth.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
